O
Odyssey Therapeutics, Inc.
ODTX · NASDAQ · Healthcare · 996M
Price · close
$26.39
+6.97% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-3.0×
Free cash flow yieldFCF yield
-28.9%
Return on equityROE
30.4%
Operating margin
-5415.2%
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
-9479.8×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.